Ironwood Investment Counsel LLC Trims Position in Cardinal Health, Inc. $CAH

Posted by Geri Gentry on May 18th, 2026

Ironwood Investment Counsel LLC trimmed its holdings in Cardinal Health, Inc. (NYSE:CAH – Free Report) by 11.2% in the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 22,395 shares of the company’s stock after selling 2,823 shares during the period. Ironwood Investment Counsel LLC’s holdings in Cardinal Health were worth $4,602,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. Aventura Private Wealth LLC purchased a new stake in shares of Cardinal Health in the fourth quarter valued at about $25,000. Elyxium Wealth LLC purchased a new stake in shares of Cardinal Health in the fourth quarter valued at about $34,000. Barnes Dennig Private Wealth Management LLC raised its holdings in shares of Cardinal Health by 38.7% in the fourth quarter. Barnes Dennig Private Wealth Management LLC now owns 190 shares of the company’s stock valued at $39,000 after buying an additional 53 shares during the last quarter. JPL Wealth Management LLC purchased a new stake in shares of Cardinal Health in the third quarter valued at about $31,000. Finally, Turning Point Benefit Group Inc. purchased a new stake in shares of Cardinal Health in the third quarter valued at about $31,000. 87.17% of the stock is owned by hedge funds and other institutional investors.

Cardinal Health Stock Down 0.1%

Shares of Cardinal Health stock opened at $195.10 on Monday. Cardinal Health, Inc. has a 52-week low of $137.75 and a 52-week high of $233.60. The company’s 50-day simple moving average is $206.96 and its 200-day simple moving average is $208.10. The firm has a market cap of $45.69 billion, a price-to-earnings ratio of 29.83, a price-to-earnings-growth ratio of 1.16 and a beta of 0.53.

Cardinal Health (NYSE:CAH – Get Free Report) last issued its quarterly earnings results on Thursday, April 30th. The company reported $3.17 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.79 by $0.38. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. The business had revenue of $60.94 billion for the quarter, compared to analyst estimates of $62.10 billion. During the same period in the previous year, the business posted $2.35 earnings per share. The business’s revenue was up 11.0% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. Equities research analysts anticipate that Cardinal Health, Inc. will post 10.76 EPS for the current year.

Cardinal Health Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Shareholders of record on Wednesday, July 1st will be given a dividend of $0.5158 per share. The ex-dividend date is Wednesday, July 1st. This is an increase from Cardinal Health’s previous quarterly dividend of $0.51. This represents a $2.06 annualized dividend and a yield of 1.1%. Cardinal Health’s dividend payout ratio (DPR) is currently 31.19%.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently commented on CAH shares. UBS Group set a $260.00 target price on shares of Cardinal Health and gave the company a “buy” rating in a report on Friday, February 6th. Citigroup reduced their target price on shares of Cardinal Health from $249.00 to $245.00 and set a “buy” rating for the company in a report on Friday, May 1st. Barclays boosted their price target on shares of Cardinal Health from $243.00 to $258.00 and gave the stock an “overweight” rating in a research note on Tuesday, February 24th. Zacks Research upgraded shares of Cardinal Health from a “hold” rating to a “strong-buy” rating in a research note on Thursday, February 12th. Finally, TD Cowen boosted their price target on shares of Cardinal Health from $251.00 to $255.00 and gave the stock a “buy” rating in a research note on Friday, May 1st. One investment analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and two have given a Hold rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $241.80.

Get Our Latest Report on CAH

Cardinal Health Profile

(Free Report)

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.